Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A Multiomic Analysis of Waldenstrom's Macroglobulinemia Identifies Three Subtypes of Disease Based on Impaired Plasma Cell Differentiation

Blood (2024) 144 (Supplement 1): 857.

https://doi.org/10.1182/blood-2024-210654

Published: 2024

Journal Articles

Artificial Intelligence Versus Expert Physician Assessments of Real-World Hematology Cases: Implications for Clinical Practice

Olivia Main, Matthew Struck, John L Vaughn, Jingmei Hsu, Mohammad Abu Zaid, Shella Saint Fleur-Lominy, Marc J Braunstein

Blood (2024) 144 (Supplement 1): 7523.

https://doi.org/10.1182/blood-2024-211003

Published: 2024

Journal Articles

Mutationally Enriched Regions of the Non-Coding Genome Harbor Functionally Impactful Mutations That Dysregulate Key Genes Involved in Multiple Myeloma Pathogenesis

Blood (2024) 144 (Supplement 1): 4655.

https://doi.org/10.1182/blood-2024-211012

Published: 2024

Journal Articles

Characterization and Comparative Outcomes of Younger Multiple Myeloma Patients

Andrea Tufano-Sugarman, Shahidul Islam, Faith E Davies, Gareth Morgan, David Kaminetzky, Oscar B Lahoud, Marc J Braunstein

Blood (2024) 144 (Supplement 1): 5155.

https://doi.org/10.1182/blood-2024-211737

Published: 2024

Journal Articles

Genomic Analysis of Endothelial Progenitor Cells In Multiple Myeloma Reveals Aberrant Gene Pathways Common to Tumor Cells

Marc J Braunstein, Sadeaqua Scott, Eric LP Smith, Danielle F Joseph, Jason Gonsky, Ruben Carrasco, Kumar Sukhdeo, Alexei Protopopov, Kenneth C Anderson, Olcay Batuman

Blood (2010) 116 (21): 3016.

https://doi.org/10.1182/blood.V116.21.3016.3016

Published: 2010

Journal Articles

Characterization of Hemangioblastic Traits within Endothelial Progenitor Cells of Multiple Myeloma Patients

Sadeaqua S Scott, PhD, Marc J Braunstein, MD/PhD, Christopher Lange, PhD, Christopher Roman, PhD, Eric LP Smith, PhD, Danielle F Joseph, PhD,, Olcay Batuman, MD

Blood (2010) 116 (21): 2984.

https://doi.org/10.1182/blood.V116.21.2984.2984

Published: 2010

Journal Articles

Junctional Adhesion Molecule-A/F11 Receptor (JAM-A/F11R) Is a Novel Biomarker and a Potential Treatment Target In Multiple Myeloma Tumor and Its Microvascular Milieu

Bani M Azari, MD/PhD, Danielle F Joseph, PhD, Marc J Braunstein, MD/PhD, H. Uwe Klueppelberg, MD, Eric LP Smith, PhD, Sadeaqua Scott, PhD, Jonathan D Marmur, MD, Anna Babinska, PhD, Olcay Batuman, MD

Blood (2010) 116 (21): 450.

https://doi.org/10.1182/blood.V116.21.450.450

Published: 2010

Journal Articles

Junctional Adhesion Molecule-A/ F11 Receptor (JAM-A/ F11R) Expression in Multiple Myeloma (MM): a Candidate Biomarker of Aggressive Disease.

Bani M Azari, MD/PhD, Marc J. Braunstein, MD/PhD, H. Uwe Kluppelberg, MD, Sadeaqua S Scott, PhD, Eric LP Smith, PhD, Jonathan D. Marmur, MD, Anna Babinska, PhD, Olcay Batuman, MD

Blood (2009) 114 (22): 2830.

https://doi.org/10.1182/blood.V114.22.2830.2830

Published: 2009

Journal Articles

Endothelial Progenitor Cells within the Bone Marrow Microenvironment of Multiple Myeloma Patients Display Stem Cell Traits.

Sadeaqua S. Scott, BS, Marc J. Braunstein, BS, Christopher Lange, PhD, Christopher Roman, PhD, Uwe Klueppelberg, MD, Olcay Batuman, MD

Blood (2009) 114 (22): 2816.

https://doi.org/10.1182/blood.V114.22.2816.2816

Published: 2009

Journal Articles

Targeting Hsp70 in Multiple Myeloma Induces Synergistic Cytotoxicity with Inhibitors of the Proteasome and of Hsp90

Marc J Braunstein, Craig M Scott, Shannon Behrman, Peter Walter, PhD, Peter Wipf, PhD, Eric LP Smith, PhD, Sadeaqua S Scott, BA, H. Uwe Klueppelberg, MD, Jeffrey L Brodsky, PhD, Olcay Batuman, MD

Blood (2008) 112 (11): 5160.

https://doi.org/10.1182/blood.V112.11.5160.5160

Published: 2008

Journal Articles

Genome-Wide Profiling of Endothelial Progenitor Cells in Multiple Myeloma: Disease-Relevant Pathways and Overlaps with Common Cancer Biomarkers

Marc J. Braunstein, Fabien Campagne, PhD, Piali Mukherjee, Daniel Ruben Carrasco, M.D., Ph.D., Kumar Sukhdeo, Alexei Protopopov, Kenneth C Anderson, MD, Olcay Batuman, MD

Blood (2008) 112 (11): 626.

https://doi.org/10.1182/blood.V112.11.626.626

Published: 2008

Journal Articles

Genome-Wide Profiling of Endothelial Progenitor Cells in Multiple Myeloma: Overlaps with Myeloma Tumor Cells and Common Cancer Gene-Pathways.

Marc J. Braunstein, Daniel R. Carrasco, Fabien Campagne, Piali Mukherjee, Kumar Sukhdeo, Alexei Protopopov, Kenneth C. Anderson, Olcay A. Batuman

Blood (2007) 110 (11): 394.

https://doi.org/10.1182/blood.V110.11.394.394

Published: 2007

Journal Articles

Clonotypic Bone Marrow-Derived Endothelial Progenitor Cells in Multiple Myeloma.

Marc J. Braunstein, MD, PhD, Daniel R. Carrasco, MD,PhD, David Kahn, MD, Kumar Sukhdeo, PhD, Alexei Protopopov, PhD, Yunyu Zhang, Kenneth C. Anderson, MD, Olcay Batuman, MD

Blood (2006) 108 (11): 3497.

https://doi.org/10.1182/blood.V108.11.3497.3497

Published: 2006

Journal Articles

Differential Effects of Hsp70 Inhibition within the Tumor and Microenvironment in Multiple Myeloma.

Marc J. Braunstein, MD, PhD, Na Liu, MD, Uwe Klueppelberg, MD,PhD, Craig Scott, Shannon Behrman, Can Tamucin, Peter Walter, PhD, Peter Wipf, PhD, Jeffrey Brodsky, PhD, Olcay Batuman, MD

Blood (2006) 108 (11): 5070.

https://doi.org/10.1182/blood.V108.11.5070.5070

Published: 2006

Journal Articles

Treatment of Newly Diagnosed, Inner-City Multiple Myeloma Patients with Zoledronate, Dexamethasone, and Low-Dose Thalidomide: A Phase II Trial.

Uwe Klueppelberg, MD, PhD, Eric L.P. Smith, PhD, Marc J. Braunstein, MD, PhD candidate, David Kahn, MD, Olcay A. Batuman, MD

Blood (2006) 108 (11): 5124.

https://doi.org/10.1182/blood.V108.11.5124.5124

Published: 2006

NARROW

A Multiomic Analysis of Waldenstrom's Macroglobulinemia Identifies Three Subtypes of Disease Based on Impaired Plasma Cell Differentiation

Artificial Intelligence Versus Expert Physician Assessments of Real-World Hematology Cases: Implications for Clinical Practice

Mutationally Enriched Regions of the Non-Coding Genome Harbor Functionally Impactful Mutations That Dysregulate Key Genes Involved in Multiple Myeloma Pathogenesis

Characterization and Comparative Outcomes of Younger Multiple Myeloma Patients

Genomic Analysis of Endothelial Progenitor Cells In Multiple Myeloma Reveals Aberrant Gene Pathways Common to Tumor Cells

Characterization of Hemangioblastic Traits within Endothelial Progenitor Cells of Multiple Myeloma Patients

Junctional Adhesion Molecule-A/F11 Receptor (JAM-A/F11R) Is a Novel Biomarker and a Potential Treatment Target In Multiple Myeloma Tumor and Its Microvascular Milieu

Junctional Adhesion Molecule-A/ F11 Receptor (JAM-A/ F11R) Expression in Multiple Myeloma (MM): a Candidate Biomarker of Aggressive Disease.

Endothelial Progenitor Cells within the Bone Marrow Microenvironment of Multiple Myeloma Patients Display Stem Cell Traits.

Targeting Hsp70 in Multiple Myeloma Induces Synergistic Cytotoxicity with Inhibitors of the Proteasome and of Hsp90

Genome-Wide Profiling of Endothelial Progenitor Cells in Multiple Myeloma: Disease-Relevant Pathways and Overlaps with Common Cancer Biomarkers

Genome-Wide Profiling of Endothelial Progenitor Cells in Multiple Myeloma: Overlaps with Myeloma Tumor Cells and Common Cancer Gene-Pathways.

Clonotypic Bone Marrow-Derived Endothelial Progenitor Cells in Multiple Myeloma.

Differential Effects of Hsp70 Inhibition within the Tumor and Microenvironment in Multiple Myeloma.

Treatment of Newly Diagnosed, Inner-City Multiple Myeloma Patients with Zoledronate, Dexamethasone, and Low-Dose Thalidomide: A Phase II Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only